Digital Limited Interaction Efficacy Trial of LifeSkills Mobile to Reduce HIV Incidence in YTW

Description

The LifeSkills Mobile app will be evaluated in a randomized controlled trial (RCT) among 5,000 young transgender women (YTW), ages 16-29 in the United States (U.S.). Study findings will demonstrate if the intervention will reduce HIV incidence.

Conditions

HIV Prevention

Talk to us

Study Overview

On this page

Study Details

Study overview

The LifeSkills Mobile app will be evaluated in a randomized controlled trial (RCT) among 5,000 young transgender women (YTW), ages 16-29 in the United States (U.S.). Study findings will demonstrate if the intervention will reduce HIV incidence.

Digital, Limited Interaction Efficacy Trial of LifeSkills Mobile to Reduce HIV Incidence in Young Transgender Women

Digital Limited Interaction Efficacy Trial of LifeSkills Mobile to Reduce HIV Incidence in YTW

Condition
HIV Prevention
Intervention / Treatment

-

Contacts and Locations

Los Angeles

UCLA, Los Angeles, California, United States, 90095

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

For general information about clinical research, read Learn About Studies.

Eligibility Criteria

  • * Self-identified as transgender, woman, and/or along the feminine spectrum with a male assigned sex at birth
  • * Ages 16-29
  • * HIV uninfected at enrollment visit, verified via HIV home test kit
  • * Self-reported lifetime history of condomless sex or recent history of sex (anal or vaginal in the past 12 months)
  • * Able to speak/understand English
  • * Owns a smartphone or home computer or willing to use one in the study
  • * Willing and able to provide informed consent/assent
  • * Unable to provide informed consent due to severe mental or physical illness, or substance intoxication at time of enrollment
  • * Discovery of active suicidal ideation or major mental illness (e.g. untreated psychosis or mania) at the time of the interview (these patients will be referred immediately for treatment, but may join the study when this is resolved)
  • * A positive Home HIV test kit result at baseline; these individuals will be immediately linked to HIV clinical care in their local areas.

Ages Eligible for Study

16 Years to 29 Years

Sexes Eligible for Study

MALE

Accepts Healthy Volunteers

Yes

Collaborators and Investigators

University of California, Los Angeles,

Marvin Belzer, MD, PRINCIPAL_INVESTIGATOR, Children's Hospital Los Angeles

Matthew J Mimiaga, ScD, MD, PRINCIPAL_INVESTIGATOR, University of California, Los Angeles

Lisa Kuhns, PhD, MPH, PRINCIPAL_INVESTIGATOR, Ann & Robert H Lurie Children's Hospital of Chicago

Study Record Dates

2026-02-28